Ayala Pharmaceuticals Inc (ADXS)

[mypekeispooped]

I'm on the side of Ig, Hov and others who believe Amgen bailing was not due to the science. We may all be proven wrong at the end (things happen) but for now, I look at the CR's that have prolonged life with a better quality of being. Certainly the anal cancer trial was a success and, even if used as an adjuvant, AXAL is of value. Slide 15 on the CP tells me SOMETHING appears to be improving OS in the combo trial. And there just wasn't enough data either way (IMO) to definitively prove NEO was effective or not. I think the cost of production was listed as a mitigating factor as well as Amgen moving in a different direction.